Literature DB >> 17824684

Selection of molecules based on shape and electrostatic similarity: proof of concept of "electroforms".

Andy Jennings1, Mike Tennant.   

Abstract

Molecular shape and electrostatic distribution play a crucial role in enzyme and receptor recognition and contribute extensively to binding affinity. Molecular similarity and bioisosterism are much-discussed topics in medicinal chemistry. Many molecular representations and similarity metrics are available to help drug discovery, and activities such as compound hit explosion and library design can be undertaken using them. The quality of the resulting compound series is highly dependent upon the molecular representation and similarity metric used. We have used a range of software to investigate whether molecules can be represented and compared effectively using measures of three-dimensional shape and electrostatic distribution ("electroforms"). We find that these descriptors allow for the assessment of molecular similarities using standard molecular visualization tools and offer a method for comparing molecules that may be considered superior to other methods.

Mesh:

Substances:

Year:  2007        PMID: 17824684     DOI: 10.1021/ci600549q

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  9 in total

1.  LIGSIFT: an open-source tool for ligand structural alignment and virtual screening.

Authors:  Ambrish Roy; Jeffrey Skolnick
Journal:  Bioinformatics       Date:  2014-10-21       Impact factor: 6.937

2.  LS-align: an atom-level, flexible ligand structural alignment algorithm for high-throughput virtual screening.

Authors:  Jun Hu; Zi Liu; Dong-Jun Yu; Yang Zhang
Journal:  Bioinformatics       Date:  2018-07-01       Impact factor: 6.937

Review 3.  The importance of discerning shape in molecular pharmacology.

Authors:  Sandhya Kortagere; Matthew D Krasowski; Sean Ekins
Journal:  Trends Pharmacol Sci       Date:  2009-01-31       Impact factor: 14.819

4.  Molecular similarity methods for predicting cross-reactivity with therapeutic drug monitoring immunoassays.

Authors:  Matthew D Krasowski; Mohamed G Siam; Manisha Iyer; Sean Ekins
Journal:  Ther Drug Monit       Date:  2009-06       Impact factor: 3.681

5.  Crystal structure of 3-{1-[(1-allyl-1H-indazol-6-yl)amino]-ethyl-idene}-6-methyl-2H-pyran-2,4(3H)-dione.

Authors:  Mohamed El Ghozlani; El Mostapha Rakib; Ahmed Gamouh; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-11-15

6.  Crystal structure of N-(1-acetyl-3-chloro-1H-indazol-6-yl)-4-meth-oxy-benzene-sulfonamide.

Authors:  Yassine Hakmaoui; El Mostapha Rakib; Ahmed Gamouh; Mohamed Saadi; Lahcen El Ammari
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-11-04

7.  Rh(iii)-catalyzed double C-H activation of aldehyde hydrazones: a route for functionalized 1H-indazole synthesis.

Authors:  Pan Xu; Guoqiang Wang; Zhongkai Wu; Shuhua Li; Chengjian Zhu
Journal:  Chem Sci       Date:  2016-10-07       Impact factor: 9.825

8.  Metal-free, regioselective, visible light activation of 4CzIPN for the arylation of 2H-indazole derivatives.

Authors:  Rajendhiran Saritha; Sesuraj Babiola Annes; Subburethinam Ramesh
Journal:  RSC Adv       Date:  2021-04-15       Impact factor: 3.361

9.  Fragment-hopping-based discovery of a novel chemical series of proto-oncogene PIM-1 kinase inhibitors.

Authors:  Gustavo Saluste; Maria I Albarran; Rosa M Alvarez; Obdulia Rabal; Miguel Angel Ortega; Carmen Blanco; Guido Kurz; Antonio Salgado; Paolo Pevarello; James R Bischoff; Joaquin Pastor; Julen Oyarzabal
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.